Jun 14, 2024, 14:54
Sergei Doulatov: Excited to share our latest work in Blood Cancer Discovery
Sergei Doulatov, Associate Professor, University of Washington, shared a post on X:
“Excited to share our latest work in Blood Cancer Discovery. We discover that SF3B1-mutated human HSCs are sensitized to CHK1 inhibitors due to pervasive mis-splicing of mitotic regulators. Led by Martina Sarchi, with Luca Malcovati and Robert K. Bradley.”
Read further.
Source: Sergei Doulatov/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 22:40
Dec 21, 2024, 22:37
Dec 21, 2024, 22:26
Dec 21, 2024, 19:39
Dec 21, 2024, 19:21
Dec 21, 2024, 19:19